Centene (NYSE:CNC) Updates FY 2025 Earnings Guidance

Centene (NYSE:CNC) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 7.250- for the period, compared to the consensus estimate of 7.950. The company issued revenue guidance of -.

Centene Stock Down 0.8 %

Centene stock opened at $58.88 on Wednesday. The firm has a market capitalization of $29.21 billion, a price-to-earnings ratio of 9.44, a price-to-earnings-growth ratio of 0.80 and a beta of 0.40. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. Centene has a fifty-two week low of $55.03 and a fifty-two week high of $80.59. The stock’s fifty day moving average is $60.09 and its two-hundred day moving average is $62.90.

Centene (NYSE:CNC) last posted its earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.31. Centene had a net margin of 2.03% and a return on equity of 13.85%. The firm had revenue of $40.81 billion during the quarter, compared to the consensus estimate of $38.78 billion. During the same period last year, the firm posted $0.45 EPS. The firm’s revenue for the quarter was up 3.4% on a year-over-year basis. Analysts predict that Centene will post 6.86 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Jefferies Financial Group downgraded Centene from a “hold” rating to an “underperform” rating and dropped their price target for the stock from $68.00 to $52.00 in a research report on Tuesday, December 10th. Cantor Fitzgerald reissued an “overweight” rating and issued a $90.00 target price on shares of Centene in a research note on Wednesday, December 11th. StockNews.com cut shares of Centene from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. JPMorgan Chase & Co. reissued an “overweight” rating and set a $75.00 price objective (down previously from $80.00) on shares of Centene in a research note on Tuesday, December 17th. Finally, Wells Fargo & Company lowered their target price on shares of Centene from $76.00 to $72.00 and set an “overweight” rating for the company in a research note on Friday, February 14th. One analyst has rated the stock with a sell rating, five have issued a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $79.92.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.